This week there were 24 Top Picks and 3 ETF in a wide range of industries: ETF, Financials, Technology, Healtcare, Consumer, Basic Materials, Industrials, Energy, Telecommunications and Utilities.
Here are this week’s Top Picks as selected by: David Cockfield, Fabrice Taylor, James Hodgins, Brooke Thackray, Michael Sprung, Ryan Bushell, Jaime Carrasco, Robert McWhirte, Michael Simpson and David Driscoll.
There has been a lot of talk about low volatility strategies over the past couple of years. That is great to have until it is not great to have. When you look at a lot of low volatility ETF’s, they are a bit expensive when looking at the names that are in them. He would…
A problem with low-vol ETFs is that people want this at once, which drives the prices up. That said, they are normally a good way to go, but watch the price.
XSU-T and IWM-T. They broke down in September. They should find support just below here. If it breaks down below that then it has to find the next support level.
Mid-$80s? His favorite of the Big 6. It has bigger US exposure, which would help if we go into recession.
She likes the Canadian banks and that the economy is slowing. Today's bank valuations are reflecting that. BNS-T is selling off some non-core assets. It now trades at a discount to the other Canadian banks and feels it is the time to buy this one.
Likes the financial sector. It’s been in a tight range. Found support around $22.50. There is good support at $20. Would be a buyer here.
A closed-end fund. Essentially, they are looking to own big stakes, almost like Warren Buffett style, businesses in India. She likes India a lot. It is one of the strongest stories.
They are building an integrated device allowing for two way talk within fleets. It has taken time for them to get all the certifications and approvals to get here. There were concerns that are now behind them. We need to see sales start to transpire into fleets in the US.
Makes a medical device called the PONS, which appears to dramatically improve the results of therapy for people with brain injuries. They are in an FDA 3rd round right now. Results will probably be out in Q3. If results are positive, the stock will multiply, if not the stock is going to get crushed.
They make medical devides (syringes, blood test equipment). After last year's acqusition, there are two cash-flow companies here which excites him. He's owned this for a decade. 1.3% dividend. 10% dividend and price growth. (Analysts’ price target is $270.50)
Interesting company and has been a good stock. Trading at about 15X earnings. Growing revenues in the single digits, which always worries him. Well diversified industrial.
Provides services and products to the fast food industry so your fortunes will rise and fall with the industry. Cut their dividend about a year ago. That took a lot of glow off the stock. Thinks the worst is over. You may have to wait a couple of years until it gets back to $10…
One of her favourite retailers. A little pricey when it comes to valuations, but they are the one retailer that really has been able to have consistent same-store sales growth. As a brick/mortar store one thing they have done really well is coming up with an advertising campaign that makes shopping an experience. It advertises…
He really likes this longer term downtrend break. If we get above $4 it opens the next resistance at $5. You are entering into a period of seasonal strength. He likes the setup for golds medium term.
A really volatile name in some ways. Compared to other chemical companies, they have been pushing really hard to get into more of the specialized product to get a higher margin and more diversification, but are still exposed to more of the commodity type parts of the market. A lot of the sales are going…
She does own this one and the recent pullback offers a good buy in point now. They are generating new synergies and cash flow from the potash and retail operations. The dividend yield is attractive. There was a very delayed planting season in the US, so crop yields will have to be watched going forward.…
He bought the IPO because it's run by people he likes. Solid people. They just did a capital raise in December. It's an early Silver Wheaton and they have been adding projects. The cash flow is already kicking in because three projects are already kicking in. Expect that flow to accelerate, plus capital appreciation.
Resistance at $8 in a positive patterns of reverse head-and-shoulders. The recent breakout above $7 is positive, and will likely move above $8.
Call centres taking advantage of AI, so it's more efficient. On a growth path. They have earnings momentum, raised dividend 46% last year, as debt's coming down and free cash is going up. Yield is 1.3%. (Analysts’ price target is $166.92)
Technical consulting and engineering services. Stock fell, and expectation is that earnings will get back to where it justifies the $100 price. In portfolios for kids and grandkids, just sit back and let it grow for decades. No dividend. (Analysts’ price target is $100.00)
He is quite bearish on the broader markets, but the sentiment in the energy sector in Canada has been so negative that he thinks it is undervalued. They have no debt and has 900 prime low-cost Montney drilling locations with significant infrastructure and only about 10% of it is dry gas. CEO owns about 30%…
They do share buybacks, but TRP is a step behind its peer, Enbridge which has a stronger capital structure (i.e. discontinued its DRIP). With their growth projects, they're not out of the woods just yet. Buy Enbridge instead. Also, it's so difficult to build a pipeline in Canada.
The dividend is very high. A good example of how the market doesn't want to be in fossil fuels. It's at 13% right now. It's a good company with European exposure. A great company but investors aren't buying it.
$64.70 is a low from late August and a bit lower in April. It held in there. Around $69 there is a bunch of resistance. It has had no strength against the S&P since June. We are probably going to come back to the low $60s test.
They have a big catalyst coming up at the end of the year with the big Deutsche Bucht offshore wind project in the North Sea which will bump up their free cash flow by a third. With this they can raise their dividend (nearly 5% now) or buy back shares. You should get low-teens returns…
Emera vs Fortis Utilities have done quite well after a weak 2018. These are not sexy growth stories, but they will let you sleep at night and pay a good, rising dividend.
It is well above the 200-day moving average. It is going to correct. If you want to collect the dividend is OK but if you are a growth investor you should sell.